Velcade and disease progression Patient Reports February 09, 2010

Velcade Side Effects Report #4570268-X
Velcade side effect was reported by a Health Professional from on Jan 27, 2005. Female patient, 59 years of age, weighting 125.7 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: buttock pain, difficulty in walking, disease progression, herpes zoster, joint range of motion decreased, rash . Velcade dosage: 2.15MG DAY 1,4,8,1 1/CY INTRAVENOUS. During the same period patient was treated with PREDNISONE, VICODIN, VALIUM, TORADOL, FAMVIR, MORPHINE DRIP. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4811087-6
Velcade side effect was reported by a Physician from UNITED STATES on Oct 10, 2005. Female patient, 55 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, chills, conjunctival hyperaemia, cryoglobulinaemia, disease progression, endocarditis bacterial, myalgia, neutropenia, oedema. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB, VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE. Patient died on 09/02/2005.

Velcade Side Effects Report #5366208-6
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, neoplasm malignant. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.

Velcade Side Effects Report #5366217-7
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.


Velcade Side Effects Report #5366218-9
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.30 MG/M2,UNK, IV BOLUS. Patient died.

Velcade Side Effects Report #5366220-7
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.

Velcade Side Effects Report #5368524-0
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.30 MG/M2, IV BOLUS. Patient died.

Velcade Side Effects Report #5368526-4
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.30 MG/M2, IV BOLUS. Patient died.

Velcade Side Effects Report #5242611-X
Velcade side effect was reported by a Physician from UNITED STATES on Feb 01, 2007. Male patient, 74 years of age, weighting 145.1 lb, was diagnosed with tongue cancer metastatic and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, pain , pneumonia . Velcade dosage: 2.90 MG, INTRAVENOUS. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient died on 11/03/2005.


Velcade Side Effects Report #5341171-2
Velcade side effect was reported by a Physician from UNITED STATES on May 15, 2007. Male patient, 74 years of age, weighting 145.1 lb, was diagnosed with tongue cancer metastatic and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, inadequate analgesia, lung consolidation, pain , pneumonia , pulmonary haemorrhage, pulmonary oedema. Velcade dosage: 1.60 MG/M2, INTRAVENOUS. During the same period patient was treated with TAXOTERE, VITAMINS, LEVOTHYROXINE. Patient was hospitalized. Patient died on 10/28/2005.

Velcade Side Effects Report #5329728-6
Velcade side effect was reported by a Physician from FRANCE on May 03, 2007. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, abdominal rigidity, c-reactive protein increased, chest pain , cough, disease progression, febrile neutropenia, haemoglobin decreased, histiocytosis haematophagic. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5429387-8
Velcade side effect was reported by a Physician from FRANCE on Aug 13, 2007. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, abdominal rigidity, anaemia, c-reactive protein increased, condition aggravated, cough, disease progression, epistaxis, febrile neutropenia. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5552343-6
Velcade side effect was reported by a Physician from FRANCE on Nov 27, 2007. Male patient, 59 years of age, weighting 65.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, cough, disease progression, febrile neutropenia, histiocytosis haematophagic, lymphoma , pulmonary haemorrhage, splenomegaly. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5746206-0
Velcade side effect was reported by a Physician from FRANCE on May 06, 2008. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, febrile neutropenia, haemoglobin decreased, histiocytosis haematophagic, leukopenia, lymphoma , pulmonary haemorrhage. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN SULPHATE, GRANOCYTE, ELDISINE. Patient was hospitalized. Patient died on 06/03/2006.


Velcade Side Effects Report #5034472-9
Velcade side effect was reported by a Physician from FRANCE on June 09, 2006. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia, pulmonary haemorrhage, thrombocytopenia. Velcade dosage: 2.76 MG INTRAVENOUS. During the same period patient was treated with DOXYL, CYCLOPHOSPHAMIDE, METHOTREXATE, CORTAN, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5731538-2
Velcade side effect was reported by a Physician from UNITED STATES on Apr 26, 2008. Male patient, 71 years of age, weighting 131.4 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, disease progression, haemoglobin abnormal, haemoglobin decreased, hyperglycaemia, hypoalbuminaemia, hypocalcaemia, hypotension. Velcade dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 04/30/2008.

Velcade Side Effects Report #5409038-9
Velcade side effect was reported by a Physician from UNITED STATES on July 26, 2007. Female patient, 36 years of age, weighting 68.34 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arterial injury, arthropod infestation, bacteria stool identified, cerebral ischaemia, cerebrovascular accident, disease progression, embolism, facial paresis. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN, PERCOCET, OXYCODONE, ACETAMINOPHEN, GABAPENTIN. Patient was hospitalized. Patient died on 07/20/2007.

Velcade Side Effects Report #6128889-9
Velcade side effect was reported by a Physician from UNITED STATES on Mar 11, 2009. Female patient, 48 years of age, weighting 119.3 lb, was diagnosed with salivary gland cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, white blood cell count decreased. Velcade dosage: 1.3 MG/M2 IV BOLUS. During the same period patient was treated with DOXORUBICIN. Patient died on 03/28/2006.

Velcade Side Effects Report #5974328-8
Velcade side effect was reported by a Physician from UNITED STATES on Nov 14, 2008. Male patient, 57 years of age, weighting 174.2 lb, was diagnosed with prostate cancer  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral infarction, disease progression, encephalitis , encephalopathy, memory impairment. Velcade dosage: 1.5 MG/M2 DAY 1,4,8, 11 X2 COURSE, IV BOLUS. During the same period patient was treated with BETA C, CLONAZEPAM, COLACE, COMPAZINE, LACTULOSE, FISH OIL, OXYCONTIN. Patient was hospitalized. Patient died on 01/01/2002.


Velcade Side Effects Report #5226792-X
Velcade side effect was reported by a Physician from UNITED KINGDOM on Jan 18, 2007. Male patient, 73 years of age, weighting 154.3 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, immunoglobulins increased, plasmacytoma. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, CLODRONATE DI, GABAPENTIN, ORAMORPH. Patient recovered.

Velcade Side Effects Report #5153600-8
Velcade side effect was reported by a Physician from UNITED KINGDOM on Nov 02, 2006. Male patient, 73 years of age, weighting 154.3 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, CLODRONATE DI, GABAPENTIN, ORAMORPH. Patient recovered.

Velcade Side Effects Report #5643880-4
Velcade side effect was reported by a Physician from UNITED STATES on Feb 17, 2008. Female patient, 43 years of age, weighting 174.2 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, dehydration, diarrhoea, disease progression, electrolyte imbalance, fatigue, heart rate increased, hypermagnesaemia. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with FLAVOPIRIDOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5951028-1
Velcade side effect was reported by a Physician from UNITED STATES on Oct 29, 2008. Female patient, 53 years of age, weighting 122.4 lb, was diagnosed with pancreatic carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , bacterial infection , disease progression, dizziness , hypoalbuminaemia, hypotension, nausea , pancreatic carcinoma, peritoneal infection. Velcade dosage: 1.3 MG/M2, IV BOLUS. Patient was hospitalized. Patient died on 10/16/2008.

Velcade Side Effects Report #5989563-2
Velcade side effect was reported by a Physician from UNITED STATES on Nov 27, 2008. Female patient, 53 years of age, weighting 122.4 lb, was diagnosed with pancreatic carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , ascites, bacterial infection , disease progression, dizziness , hypoalbuminaemia, hypotension, multi-organ failure, nausea . Velcade dosage: 1.3 MG/M2, IV BOLUS. Patient was hospitalized. Patient died on 10/16/2008.


Velcade Side Effects Report #5988512-0
Velcade side effect was reported by a Physician from JAPAN on Nov 27, 2008. Male patient, 62 years of age, was diagnosed with oesophageal carcinoma recurrent and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, interstitial lung disease, off label use. Velcade dosage: 0.175 MG, INTRA-ARTERIAL. During the same period patient was treated with TARCEVA, OXALIPLATIN, GEMCITABINE, MITOMYCIN, AREDIA Z. Patient was hospitalized. Patient died on 01/01/2008.

Velcade Side Effects Report #5072305-5
Velcade side effect was reported by a Physician from UNITED STATES on July 19, 2006. Male patient, 74 years of age, weighting 141.5 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, disease progression, mental status changes, mood altered, nuclear magnetic resonance imaging brain abnormal, performance status decreased. Velcade dosage: 1.30 MG//M2, UNK. During the same period patient was treated with ALIMTA, NORVASC, AVANDIA, METFORMIN, LIPITOR, PERCOCET, MOBIC, INDERAL. Patient recovered.

Velcade Side Effects Report #4717767-5
Velcade side effect was reported by a Health Professional from UNITED STATES on July 18, 2005. Male patient, 64 years of age, weighting 170.0 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, haemoptysis, metastases to central nervous system, thrombotic thrombocytopenic purpura. Velcade dosage: 1.75-1.4 MG PER PROTOCOL. During the same period patient was treated with TARCEVA, DECADRON, METROPROLOL SUCCINATE, ZESTORETIC. Patient died on 07/04/2005.

Velcade Side Effects Report #5505002-X
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 31, 2007. Female patient, 62 years of age, weighting 107.4 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, non-small cell lung cancer, pleural effusion, pneumonia , pulmonary oedema, renal failure acute, respiratory distress, troponin increased. Velcade dosage: 1.3 MG/M2 D1 AND 8 IV DRIP. Patient was hospitalized. Patient died on 10/20/2007.

Velcade Side Effects Report #5060346-3
Velcade side effect was reported by a Physician from UNITED STATES on July 05, 2006. Female patient, 61 years of age, weighting 97.00 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.00 MG/M2, UNK, IV BOLUS. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE, CARBOPLATIN. Patient died on 09/23/2004.


Velcade Side Effects Report #6130445-3
Velcade side effect was reported by a Physician from UNITED STATES on Mar 11, 2009. Male patient, 52 years of age, weighting 228.8 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: back pain , cerebral infarction, cerebral ischaemia, disease progression, facial paresis, hypoalbuminaemia, lymphopenia, muscular weakness, pulmonary embolism . Velcade dosage: 1.6 MG/M2, INTRAVENOUS. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5442834-0
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 42 years of age, weighting 138.5 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 2.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA. Patient died on 07/30/2007.

Velcade Side Effects Report #5495445-5
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 18, 2007. Female patient, 42 years of age, weighting 138.5 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, metastases to central nervous system, metastases to lymph nodes, non-small cell lung cancer. Velcade dosage: 2.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient died on 07/30/2007.

Velcade Side Effects Report #5297709-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Male patient, weighting 210.0 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchospasm, disease progression, haemoglobin abnormal, haemoptysis, performance status decreased, platelet count abnormal, pulmonary embolism , pulmonary haemorrhage, pyrexia. Velcade dosage: 1.3MG/M2 D1,D8 Q21DAY IV. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient died on 04/01/2007.

Velcade Side Effects Report #4587474-0
Velcade side effect was reported by a Physician from on Jan 25, 2005. Male patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, dyspnoea, hypotension, neutropenia, pneumonia , productive cough, renal failure acute, respiratory failure. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died on 12/22/2004.


Velcade Side Effects Report #4634789-3
Velcade side effect was reported by a Physician from on Mar 31, 2005. Male patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, anaemia, ascites, blood albumin decreased, blood ph decreased, blood pressure immeasurable, coma, disease progression, hepatosplenomegaly. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died on 12/22/2004.

Velcade Side Effects Report #4963120-9
Velcade side effect was reported by a Physician from UNITED STATES on Mar 17, 2006. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient died.

Velcade Side Effects Report #5858325-9
Velcade side effect was reported by a Physician from ISRAEL on Aug 20, 2008. Male patient, child 8 years of age, was diagnosed with neuroblastoma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: unknown. Patient died.

Velcade Side Effects Report #4952213-8
Velcade side effect was reported by a Physician from HONG KONG on Mar 02, 2006. Female patient, 57 years of age, was diagnosed with natural killer-cell lymphoblastic lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, natural killer-cell lymphoblastic lymphoma. Velcade dosage: 1.00 MG/M2, 2/WEEK. Patient died on 01/09/2006.

Velcade Side Effects Report #5500105-8
Velcade side effect was reported by a Physician from AUSTRALIA on Sept 17, 2007. Female patient, 78 years of age, was diagnosed with multiple sclerosis , multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: amyloidoma, bacterial infection , blood culture positive, catheter related complication, catheter site erythema, catheter site related reaction, cerebral haemorrhage, disease progression, dysarthria. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ROMIDEPSIN. Patient was hospitalized. Patient died on 04/17/2007.


Velcade Side Effects Report #5817474-1
Velcade side effect was reported by a Physician from SWITZERLAND on July 10, 2008. Female patient, 89 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, renal failure. Velcade dosage: 1.3 MG/M2;. During the same period patient was treated with DEXAMETHASONE. Patient died on 07/09/2007.

Velcade Side Effects Report #5552385-0
Velcade side effect was reported by a Physician from ITALY on Nov 26, 2007. Female patient, 84 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cognitive disorder, depressed level of consciousness, disease progression, hypoxic encephalopathy, left ventricular failure, psychomotor hyperactivity, sensory loss. Velcade dosage: 1.80 MG. During the same period patient was treated with MELPHALAN, PREDNISONE, FENTANYL, LANSOPRAZOLE, VASORETIC, ASPIRIN, PLASIL. Patient was hospitalized. Patient died on 10/20/2007.

Velcade Side Effects Report #5451068-5
Velcade side effect was reported by a Physician from JAPAN on Aug 28, 2007. Female patient, 83 years of age, weighting 83.78 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, disease progression, hypoaesthesia, hyponatraemia, liver disorder, neoplasm progression, nerve injury, neuropathy. Velcade dosage: 1.30 MG/M2; 1.00 MG/M2,. During the same period patient was treated with DECADRON, BAKTAR, DIFLUCAN, MUCOSTA, POLYMYXIN B SULPHATE, OMEPRAL, MAGNESIUM OXIDE. Patient was hospitalized and became disabled. Patient died on 05/27/2007.

Velcade Side Effects Report #5270156-X
Velcade side effect was reported by a Pharmacist from GREECE on Mar 05, 2007. Male patient, 82 years of age, was diagnosed with multiple myeloma , prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, muscle spasms, muscular weakness, renal failure. Velcade dosage: unknown. During the same period patient was treated with NEURONTIN, PERINDOPRIL ERBUMINE, LASIX, ALLOPURINOL, PANCORAN. Patient was hospitalized. Patient died on 10/11/2006.

Velcade Side Effects Report #6023762-9
Velcade side effect was reported by a Physician from JAPAN on Dec 16, 2008. Female patient, 82 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/10/2008.

Velcade Side Effects Report #5292583-7
Velcade side effect was reported by a Physician from NETHERLANDS on Mar 23, 2007. Male patient, 80 years of age, weighting 185.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abnormal behaviour, cognitive disorder, disease progression, disorientation, haemorrhage intracranial. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5873748-X
Velcade side effect was reported by a Physician from JAPAN on Aug 28, 2008. Male patient, 80 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 08/26/2008.

Velcade Side Effects Report #5978732-3
Velcade side effect was reported by a Physician from GERMANY on Nov 17, 2008. Male patient, 80 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, phlebitis. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DILUTOL, NITRODERM, UROLOSIN, PLAVIX, CALCIUM SANDOZTE D, OMEPRAZOLE, ALLOPURINOL, VALACYCLOVIR. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5549804-2
Velcade side effect was reported by a Physician from UNITED STATES on Nov 29, 2007. Male patient, 79 years of age, weighting 160.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood glucose abnormal, disease progression. Velcade dosage: 2.30 MG, IV BOLUS. During the same period patient was treated with ENABLEX, FLAGYL, FOLIC ACID, HUMALOG, LEXAPRO, LIPITOR, OMEPRAZOLE, TRAVATAN. Patient died on 11/08/2006.

Velcade Side Effects Report #5724964-9
Velcade side effect was reported by a Physician from ISRAEL on Apr 17, 2008. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma , pneumonia . Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with CADEX, OXYCOD, EPREX, DURAGESIC. Patient was hospitalized. Patient died on 02/29/2008.


Velcade Side Effects Report #5316527-4
Velcade side effect was reported by a Physician from AUSTRALIA on Apr 18, 2007. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, disease progression, hyperviscosity syndrome, thrombocytopenia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ROMIDEPSIN. Patient died on 04/17/2007.

Velcade Side Effects Report #5509025-6
Velcade side effect was reported by a Physician from AUSTRALIA on Oct 24, 2007. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: amyloidosis, cerebral haemorrhage, disease progression, febrile infection, hyperviscosity syndrome, infusion site infection, thrombocytopenia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ROMIDEPSIN. Patient was hospitalized. Patient died on 04/17/2007.

Velcade Side Effects Report #5578226-3
Velcade side effect was reported by a Physician from JAPAN on Dec 10, 2007. Female patient, 78 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, diarrhoea, disease progression, nausea , platelet count decreased, pulmonary oedema, pyrexia, treatment failure, white blood cell count decreased. Velcade dosage: 1.90MG, INTRAVENOUS; 1.70 MG, INTRAVENOUS; 1.30MG, INTRAVENOUS; 1.90MG, INTRAVENOUS. During the same period patient was treated with PREDNONINE, HYDROCORTISONE, WARFARIN, ACECOL, ENDOXAN. Patient was hospitalized. Patient died on 05/12/2007.

Velcade Side Effects Report #5612827-9
Velcade side effect was reported by a Health Professional from COLOMBIA on Jan 17, 2008. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, pneumonia . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/01/2007.

Velcade Side Effects Report #5984815-4
Velcade side effect was reported by a Physician from JAPAN on Nov 20, 2008. Male patient, 78 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, disease progression, gastrointestinal haemorrhage, hyperkalaemia, hypotension. Velcade dosage: 1.5 MG, INTRAVENOUS. During the same period patient was treated with CANDESARTAN CILEXETIL, ALLOPURINOL, KAYEXALATE, MOBIC, METHYCOBAL, PURSENNID, OXYCONTIN, MAGNESIUM OXIDE. Patient died on 10/15/2008.

Velcade Side Effects Report #4877339-9
Velcade side effect was reported by a Physician from CANADA on Dec 22, 2005. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, cerebral atrophy, cerebral ischaemia, confusional state, disease progression, herpes zoster disseminated, lumbar puncture abnormal, multiple myeloma , myopathy steroid. Velcade dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with PAMIDRONATE DI, BENADRYL, ACETAMINOPHEN, LORAZEPAM, EPREX, DOMPERIDONE, KYTRIL, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5008491-2
Velcade side effect was reported by a Physician from CANADA on May 10, 2006. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral atrophy, cerebral ischaemia, confusional state, disease progression, haemangioma of liver, herpes zoster disseminated, hyperplastic cholecystopathy, inflammation, myopathy. Velcade dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with PAMIDRONATE DI, BENADRYL, ACETAMINOPHEN, LORAZEPAM, EPREX, DOMPERIDONE, KYTRIL, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5580691-2
Velcade side effect was reported by a Physician from JAPAN on Dec 20, 2007. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatine increased, blood urea increased, disease progression, dyspnoea, metabolic acidosis, multiple myeloma , oedema, tumour lysis syndrome, weight increased. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, SELBEX, BAKTAR, ALLOPURINOL, METHYCOBAL. Patient died on 08/03/2007.

Velcade Side Effects Report #5587235-X
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2007. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, disease progression, dyspnoea, metabolic acidosis, oedema, tumour lysis syndrome. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, SELBEX, BAKTAR, ALLOPURINOL, METHYCOBAL. Patient died on 08/03/2007.

Velcade Side Effects Report #5615699-1
Velcade side effect was reported by a Physician from JAPAN on Jan 22, 2008. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea abnormal, disease progression, dyspnoea, metabolic acidosis, oedema, tumour lysis syndrome, weight increased. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, SELBEX, BAKTAR, ALLOPURINOL, METHYCOBAL. Patient died on 08/03/2007.


Velcade Side Effects Report #5622913-5
Velcade side effect was reported by a Physician from AUSTRALIA on Jan 25, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression. Velcade dosage: 1.30 MG/M2,. Patient died.

Velcade Side Effects Report #5788960-8
Velcade side effect was reported by a Physician from PHILIPPINES on June 14, 2008. Female patient, 77 years of age, weighting 198.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma . Velcade dosage: 1.3 MG. Patient died on 09/21/2007.

Velcade Side Effects Report #4806430-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 05, 2005. Male patient, 77 years of age, weighting 159.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium decreased, cardiac failure congestive, dialysis , disease progression, disease recurrence, limb injury, mood altered, multiple myeloma , nephritis. Velcade dosage: 1.30MG/M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, LOTENSIN, INSULIN, DURAGESIC, PROTONIX, MOBIC, VITAMIN C. Patient was hospitalized. Patient died on 08/26/2005.

Velcade Side Effects Report #5165149-7
Velcade side effect was reported by a Physician from PORTUGAL on Nov 13, 2006. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, cardiac failure, disease progression, infection , neuropathy. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5495515-1
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 12, 2007. Female patient, 76 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.79 MG,. Patient was hospitalized. Patient died on 09/29/2007.

Velcade Side Effects Report #5552382-5
Velcade side effect was reported by a Physician from JAPAN on Nov 28, 2007. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, deep vein thrombosis , disease progression, neuropathy peripheral, neutrophil count decreased, platelet count decreased, pulmonary embolism , pyrexia. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, LASIX, PIPERACILLIN AND TAZOBACTAM, NORVASC, MUCOSTA, LANSOPRAZOLE, RIZE. Patient died on 10/29/2007.

Velcade Side Effects Report #5633209-X
Velcade side effect was reported by a Physician from JAPAN on Feb 05, 2008. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bedridden, blood lactate dehydrogenase increased, c-reactive protein increased, catheter related complication, deep vein thrombosis , disease progression, immobile, neuropathy peripheral, neutrophil count decreased. Velcade dosage: 1.90 MG, 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, LASIX, PIPERACILLIN AND TAZOBACTAM, NORVASC, MUCOSTA, LANSOPRAZOLE. Patient died on 10/29/2007.

Velcade Side Effects Report #5678125-2
Velcade side effect was reported by a Physician from JAPAN on Mar 07, 2008. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bedridden, catheter related complication, deep vein thrombosis , disease progression, neuropathy peripheral, oedema peripheral, pulmonary embolism , tumour lysis syndrome. Velcade dosage: 1.90 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, LASIX, PIPERACILLIN AND TAZOBACTAM, NORVASC, MUCOSTA, LANSOPRAZOLE. Patient died on 10/29/2007.

Velcade Side Effects Report #5827254-9
Velcade side effect was reported by a Physician from JAPAN on July 17, 2008. Male patient, 76 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression, pneumonia . Velcade dosage: unknown. Patient died on 06/10/2008.

Velcade Side Effects Report #5828787-1
Velcade side effect was reported by a Physician from JAPAN on July 18, 2008. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 01/13/2008.


Velcade Side Effects Report #5912908-6
Velcade side effect was reported by a Physician from JAPAN on Sept 24, 2008. Female patient, 76 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthma , blood amylase increased, c-reactive protein increased, disease progression, platelet count decreased, pyrexia, rash , white blood cell count decreased. Velcade dosage: 1.74 MG, INTRAVENOUS. During the same period patient was treated with FAMOTIDINE, ALLOPURINOL, METHYCOBAL, INDACIN, FLUTIDE INHALATION, SEREVENT. Patient died on 07/14/2008.

Velcade Side Effects Report #5937610-6
Velcade side effect was reported by a Physician from JAPAN on Oct 17, 2008. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. Patient died on 09/22/2008.

Velcade Side Effects Report #6009154-7
Velcade side effect was reported by a Pharmacist from UNITED STATES on Dec 04, 2008. Female patient, 76 years of age, weighting 185.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, herpes zoster, rash . Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #4791642-2
Velcade side effect was reported by a Physician from GERMANY on Sept 20, 2005. Female patient, 76 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, dehydration, disease progression, multiple myeloma . Velcade dosage: 1.50 MG, INTRAVENOUS. During the same period patient was treated with NOVALGIN, TEMGESIC. Patient was hospitalized. Patient died on 09/14/2005.

Velcade Side Effects Report #4791916-5
Velcade side effect was reported by a Physician from GERMANY on Sept 20, 2005. Female patient, 76 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, dehydration, disease progression. Velcade dosage: 1.50 MG, INTRAVENOUS. During the same period patient was treated with NOVALGIN, TEMGESIC. Patient was hospitalized. Patient died on 09/14/2005.

Velcade Side Effects Report #4944209-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 21, 2006. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure orthostatic decreased, disease progression, dizziness , haematocrit decreased, haematotoxicity, haemoglobin decreased, heart rate increased, multiple myeloma , thrombocytopenia. Velcade dosage: 2.80 MG, INTRAVENOUS. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #5580115-5
Velcade side effect was reported by a Physician from JAPAN on Dec 20, 2007. Male patient, 75 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, fungal infection , gastrointestinal haemorrhage, sepsis , telangiectasia. Velcade dosage: MG, INTRAVENOUS. During the same period patient was treated with TIZANIDINE, ALFAROL, LANSOPRAZOLE, SELBEX, MAGNESIUM OXIDE, AMARYL, DICLOFENAC, DEXAMETHASONE. Patient was hospitalized. Patient died on 05/27/2007.

Velcade Side Effects Report #5804277-7
Velcade side effect was reported by a Physician from JAPAN on June 30, 2008. Male patient, 75 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal discomfort, diarrhoea, disease progression, neuropathy peripheral, platelet count decreased, pyrexia. Velcade dosage: 2.3 MG, INTRAVENOUS; 1.8 MG, INTRAVENOUS. During the same period patient was treated with MAGTECT, PURSENNID, LENDORM, MECOBALAMIN, NEUROTROPIN, MAGNESIUM OXIDE. Patient died on 05/16/2008.

Velcade Side Effects Report #5811338-5
Velcade side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 75 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased. Velcade dosage: 2.3 MG, INTRAVENOUS; 1.8 MG, INTRAVENOUS. During the same period patient was treated with MAGTECT, PURSENNID, LENDORM, MECOBALAMIN, NEUROTROPIN, MAGNESIUM OXIDE. Patient died on 05/16/2008.

Velcade Side Effects Report #5817612-0
Velcade side effect was reported by a Physician from JAPAN on July 09, 2008. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, leukoencephalopathy, neoplasm. Velcade dosage: 1.70 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 03/18/2008.


Velcade Side Effects Report #5839493-1
Velcade side effect was reported by a Physician from JAPAN on July 28, 2008. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: depressed level of consciousness, diplegia, disease progression, disorientation, dysstasia, leukoencephalopathy, nuclear magnetic resonance imaging abnormal, paresis, pyrexia. Velcade dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OXYCONTIN, ETODOLAC, RIZE, DOGMATYL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LENDORM, ZANTAC. Patient was hospitalized. Patient died on 03/18/2008.

Velcade Side Effects Report #5885683-1
Velcade side effect was reported by a Physician from JAPAN on Sept 03, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma . Velcade dosage: unknown. Patient died on 08/15/2008.

Velcade Side Effects Report #5930789-1
Velcade side effect was reported by a Physician from JAPAN on Oct 12, 2008. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diplegia, disease progression, disorientation, dysstasia, leukoencephalopathy, paresis, platelet count decreased, pyrexia. Velcade dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OXYCONTIN, ETODOLAC, RIZE, DOGMATYL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LENDORM, ZANTAC. Patient was hospitalized. Patient died on 03/18/2008.

Velcade Side Effects Report #5989650-9
Velcade side effect was reported by a Physician from JAPAN on Nov 25, 2008. Female patient, 75 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, haematotoxicity, movement disorder , nerve compression, oedema, peripheral sensorimotor neuropathy, plasmacytoma, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LANSOPRAZOLE, FLUCONAZOLE. Patient died on 11/05/2008.

Velcade Side Effects Report #6021679-7
Velcade side effect was reported by a Physician from JAPAN on Dec 09, 2008. Female patient, 75 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: amyloidosis, disease progression, haematotoxicity, peripheral sensorimotor neuropathy, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LANSOPRAZOLE, FLUCONAZOLE. Patient was hospitalized and became disabled. Patient died on 11/05/2008.

Velcade Side Effects Report #6123948-9
Velcade side effect was reported by a Physician from JAPAN on Mar 06, 2009. Female patient, 75 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, amyloidosis, depressed level of consciousness, disease progression, haematotoxicity, joint contracture, movement disorder , multiple myeloma , nerve compression. Velcade dosage: 1.8 MG, UNK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LANSOPRAZOLE, FLUCONAZOLE. Patient was hospitalized and became disabled. Patient died on 11/05/2008.

Velcade Side Effects Report #4830543-8
Velcade side effect was reported by a Pharmacist from UNITED STATES on Oct 26, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, disease progression, international normalised ratio increased, prothrombin time prolonged, thrombocytopenia. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with COUMADIN, ATENOLOL, VEXOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, TYLENOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5153599-4
Velcade side effect was reported by a Physician from NETHERLANDS on Nov 01, 2006. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomyopathy , disease progression, mitral valve incompetence, ventricular hypokinesia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died.

Velcade Side Effects Report #5572347-7
Velcade side effect was reported by a Physician from JAPAN on Dec 14, 2007. Male patient, 74 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased, tumour lysis syndrome, varicella. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE, ROHYPNOL, URINORM, NORVASC, METHYCOBAL, AMITRIPTYLINE, ITRACONAZOLE, BAKTAR. Patient was hospitalized. Patient died on 07/10/2007.

Velcade Side Effects Report #5642145-4
Velcade side effect was reported by a Physician from JAPAN on Feb 13, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, nausea , pneumonia aspiration, pyrexia, thrombocytopenia. Velcade dosage: 1.80 MG, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with HYDROCORTISONE SUCCINATE, NIFEDIPINE, PROTECADIN, ALLOPURINOL, BICARBONATE, SOLITA T, PRIMPERAN. Patient died on 10/23/2007.

Velcade Side Effects Report #5663527-0
Velcade side effect was reported by a Physician from JAPAN on Feb 22, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: altered state of consciousness, constipation , diarrhoea, disease progression, hypoaesthesia, nausea , pneumonia aspiration, renal impairment, thrombocytopenia. Velcade dosage: 1.80 MG, INTRAVENOUS; 1.40 MG, INTRAVENOUS; 1.00 MG, INTRAVENOUS. During the same period patient was treated with HYDROCORTISONE SUCCINATE, NIFEDIPINE, PROTECADIN, ALLOPURINOL, BICARBONATE, SOLITA T. Patient was hospitalized. Patient died on 10/23/2007.

Velcade Side Effects Report #5679486-0
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2008. Male patient, 74 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: decreased appetite, diarrhoea, disease progression, hyperuricaemia, neuropathy peripheral, pyrexia, thrombocytopenia, tumour lysis syndrome. Velcade dosage: 2.00 MG,INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, AMLODIPINE BESYLATE, URALYT, DIFLUCAN, VALSARTAN, BAKTAR, LAFUTIDINE, FOSAMAX. Patient died on 10/13/2007.

Velcade Side Effects Report #5706377-9
Velcade side effect was reported by a Physician from JAPAN on Mar 31, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: altered state of consciousness, blood sodium decreased, dehydration, diarrhoea, disease progression, pneumonia aspiration, renal failure. Velcade dosage: 1.80 MG, INTRAVENOUS; 1.40 MG, INTRAVENOUS; 1.00 MG, INTRAVENOUS. During the same period patient was treated with HYDROCORTISONE SUCCINATE, NIFEDIPINE, PROTECADIN, ALLOPURINOL, BICARBONATE, SOLITA T. Patient was hospitalized. Patient died on 10/23/2007.

Velcade Side Effects Report #5723041-0
Velcade side effect was reported by a Physician from SWITZERLAND on Apr 22, 2008. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, haemolysis, multiple myeloma . Velcade dosage: unknown. Patient died.

Velcade Side Effects Report #5981835-0
Velcade side effect was reported by a Physician from UNITED STATES on Nov 17, 2008. Female patient, 74 years of age, weighting 166.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: back pain , depression , disease progression, disease recurrence, fatigue, glossodynia, hypoaesthesia, neutropenia, no therapeutic response. Velcade dosage: 1 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, XANAX, LACTULOSE, SONATA, EFFEXOR. Patient recovered.

Velcade Side Effects Report #5989600-5
Velcade side effect was reported by a Physician from JAPAN on Nov 25, 2008. Female patient, 74 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression. Velcade dosage: 1.3 MG, INTRAVENOUS. Patient died on 11/25/2008.

Velcade Side Effects Report #6029111-4
Velcade side effect was reported by a Physician from JAPAN on Dec 24, 2008. Male patient, 74 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, anaemia, bacterial infection , c-reactive protein increased, disease progression, hypersensitivity, hypoaesthesia, hypokalaemia, leukopenia. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, DEXAMETHASONE, AREDIA, MAXIPIME, PLATELETS, POLARAMINE, KYTRIL, LASIX. Patient died on 07/22/2008.

Velcade Side Effects Report #6131817-3
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2009. Male patient, 74 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased, tumour lysis syndrome, varicella. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ROHYPNOL, URINORM, NORVASC, METHYCOBAL, AMITRIPTYLINE, ITRIZOLE, BAKTAR. Patient was hospitalized. Patient died on 07/10/2007.

Velcade Side Effects Report #4616812-5
Velcade side effect was reported by a Health Professional from on Feb 08, 2005. Male patient, 74 years of age, weighting 201.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, erythema multiforme, fatigue, herpes simplex , nausea , white blood cell count decreased. Velcade dosage: unknown. During the same period patient was treated with COUMADIN, ZOCOR, DILTIAZEM, DOXAZOSIN, DIOVAN, DIGOXIN, FUROSEMIDE. Patient died.

Velcade Side Effects Report #4781705-X
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 12, 2005. Male patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, laboratory test abnormal, renal impairment. Velcade dosage: 2.50 MG. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient died on 08/01/2005.

Velcade Side Effects Report #4802185-1
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 27, 2005. Male patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, disease progression, hepatic neoplasm, laboratory test abnormal. Velcade dosage: 2.50 MG. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient died on 09/05/2005.